DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-799 Cr | ₹-799 Cr | ₹-797 Cr | ₹-532 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-799 Cr |
| Mar2024 | ₹-799 Cr |
| Mar2023 | ₹-797 Cr |
| Mar2022 | ₹-532 Cr |
| Mar2021 | ₹-35 Cr |
How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-799 Cr | Negative | |
| Mar2024 | ₹-799 Cr | Negative | |
| Mar2023 | ₹-797 Cr | Negative | |
| Mar2022 | ₹-532 Cr | Negative | |
| Mar2021 | ₹-35 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹168,396.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,782.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,225.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,174.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,629.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
| MANKIND PHARMA | ₹89,293.9 Cr | 0.1% | -1.5% | -25.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.6% |
-0.4% |
9.4% |
| SENSEX | -0.3% |
-0.5% |
8.3% |
You may also like the below Video Courses